Diagnostic options · UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 2611–2625 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-6257 TRMT5 Gene Test This test identifies pathogenic variants in the TRMT5 gene associated with Combined Oxidative Phosphorylation Deficiency Type 26 (COXPD26).	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TRMT5 gene", "Single nucleotide variants", "Small insertions/deletions"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed therapy without consultation"] Indications ["Suspected Combined Oxidative Phosphorylation Deficiency Type 26 (COXPD26)", "Individuals with clinical features suggestive of mitochondrial disorders"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: E74.81 Clinical summary This test identifies pathogenic variants in the TRMT5 gene associated with Combined Oxidative Phosphorylation Deficiency Type 26 (COXPD26).
TEST-5600 TRMU Gene Mitochondrial Modifier of Deafness Genetic Test This genetic test evaluates the TRMU gene for pathogenic variants linked to hereditary sensorineural hearing loss.	Peripheral Whole Blood	21 to 28 Days (3 to 4 Weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TRMU gene", "Mitochondrial tRNA modification enzyme function"] Parameters [] Preparation [] Indications ["Suspected hereditary sensorineural hearing loss", "Evaluation of mitochondrial-mediated hearing impairment"] Measurement technique Confirm with laboratory Codes LOINC: 82121-5 ICD-10: H90.5, H90.3, Z15.89 Clinical summary This genetic test evaluates the TRMU gene for pathogenic variants linked to hereditary sensorineural hearing loss.
TEST-3658 TRMU Gene Transient Infantile Liver Failure Genetic Test This test detects pathogenic variants in the TRMU gene associated with transient infantile liver failure using next-generation sequencing.	Whole blood (EDTA) or FTA card blood spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TRMU gene", "Full coding region, splice sites, and flanking intronic regions"] Parameters [] Preparation ["No fasting required", "No specific medication or diet instructions"] Indications ["Infants presenting with acute, reversible liver failure", "Family history suggestive of TRMU-related liver disease"] Measurement technique Confirm with laboratory Codes LOINC: 94219-0 ICD-10: K72.90 Clinical summary This test detects pathogenic variants in the TRMU gene associated with transient infantile liver failure using next-generation sequencing.
TEST-3823 TRPC6 Gene Focal Segmental Glomerulosclerosis Type 2 Genetic Test This test identifies pathogenic variants in the TRPC6 gene associated with autosomal dominant focal segmental glomerulosclerosis type 2 (FSGS2).	Peripheral Whole Blood (3–5 mL in EDTA tube) or Dried Blood Spot on FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TRPC6 gene", "Copy Number Variations (CNV) in the TRPC6 gene"] Parameters [] Preparation [] Indications ["Confirmation of clinical diagnosis of FSGS2", "Guiding treatment decisions", "Family screening"] Measurement technique Confirm with laboratory Codes LOINC: 87851-7 ICD-10: N04.1, Z13.7 Clinical summary This test identifies pathogenic variants in the TRPC6 gene associated with autosomal dominant focal segmental glomerulosclerosis type 2 (FSGS2).
TEST-3828 TRPM7 Gene Susceptibility Test for ALS‑Parkinsonism/Dementia Complex This test identifies pathogenic or likely pathogenic variants in the TRPM7 gene, indicating an increased lifetime susceptibility to the ALS-parkinsonism/dementia complex.	Whole Blood (EDTA tube) or FTA Card (Dried Blood Spot)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TRPM7 gene"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication"] Indications ["Individuals with a family history of ALS-parkinsonism/dementia complex", "Risk assessment for individuals with suggestive neurological symptoms"] Measurement technique Confirm with laboratory Codes LOINC: 21636-5 ICD-10: Z15.89 Clinical summary This test identifies pathogenic or likely pathogenic variants in the TRPM7 gene, indicating an increased lifetime susceptibility to the ALS-parkinsonism/dementia complex.
TEST-4523 TRPS1 Gene (Trichorhinophalangeal Syndrome Type 1) Genetic Test This test identifies pathogenic variants in the TRPS1 gene associated with Trichorhinophalangeal Syndrome Type 1.	Whole Blood (3–5 mL) or Dried Blood Spot (FTA Card)	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TRPS1 gene", "Full coding exons and splice sites"] Parameters [] Preparation ["No fasting required"] Indications ["Clinical suspicion of Trichorhinophalangeal Syndrome Type 1 (TRPS I)", "Family history of TRPS I"] Measurement technique Confirm with laboratory Codes LOINC: 94218-9 ICD-10: Q87.1 Clinical summary This test identifies pathogenic variants in the TRPS1 gene associated with Trichorhinophalangeal Syndrome Type 1.
TEST-2665 TRPS1 Gene Langer‑Giedion Syndrome Genetic Test This test detects pathogenic variants in the TRPS1 gene to confirm a diagnosis of Langer‑Giedion syndrome.	Peripheral Whole Blood (EDTA), Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TRPS1 gene", "Point mutations", "Small insertions/deletions", "Copy number variations"] Parameters [] Preparation ["Genetic counselling session required", "Signed informed consent required"] Indications ["Clinical suspicion of Langer‑Giedion syndrome", "Family history of Langer‑Giedion syndrome", "Carrier testing", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q87.1 Clinical summary This test detects pathogenic variants in the TRPS1 gene to confirm a diagnosis of Langer‑Giedion syndrome.
TEST-5587 TSEN2 Gene Pontocerebellar Hypoplasia Type 2B Genetic Test This genetic test identifies mutations in the TSEN2 gene associated with pontocerebellar hypoplasia type 2B.	Whole blood (3–5 mL in EDTA tube), Extracted DNA, or Dried Blood Spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TSEN2 gene"] Parameters [] Preparation ["Completed clinical history form", "Mandatory genetic counseling session", "Signed informed consent"] Indications ["Patients with clinical signs of pontocerebellar hypoplasia", "Molecular confirmation for diagnosis", "Guiding management and prognosis", "Family counseling"] Measurement technique Confirm with laboratory Codes LOINC: 48018-6 ICD-10: G11.8 Clinical summary This genetic test identifies mutations in the TSEN2 gene associated with pontocerebellar hypoplasia type 2B.
TEST-5500 TSEN34 Gene Pontocerebellar Hypoplasia Type 2C Genetic Test This test detects pathogenic variants in the TSEN34 gene associated with pontocerebellar hypoplasia type 2C.	Whole Blood (EDTA) or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TSEN34 gene", "Single nucleotide variants", "Small insertions/deletions", "Splice-site mutations"] Parameters [] Preparation [] Indications ["Clinical suspicion of pontocerebellar hypoplasia type 2C (PCH2C)", "Carrier screening in families with PCH2C history"] Measurement technique Confirm with laboratory Codes LOINC: 81303-9 ICD-10: Q04.3, G31.8, Z13.71 Clinical summary This test detects pathogenic variants in the TSEN34 gene associated with pontocerebellar hypoplasia type 2C.
TEST-5496 TSEN54 Gene Pontocerebellar Hypoplasia Type 2A Genetic Test This diagnostic test evaluates the TSEN54 gene for pathogenic variants associated with Pontocerebellar Hypoplasia Type 2A.	Whole Blood (3-5 mL EDTA) or Saliva (Oragene DNA Kit)	14–21 calendar days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TSEN54 gene", "Single nucleotide variants", "Small insertions/deletions", "Cryptic splice mutations"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected Pontocerebellar Hypoplasia Type 2A", "Family history of PCH2A", "Neurodevelopmental disorder with cerebellar hypoplasia"] Measurement technique Confirm with laboratory Codes LOINC: 76006-3 ICD-10: Q04.8 Clinical summary This diagnostic test evaluates the TSEN54 gene for pathogenic variants associated with Pontocerebellar Hypoplasia Type 2A.
TEST-5595 TSEN54 Gene Pontocerebellar Hypoplasia Type 4 Genetic Test This genetic test sequences the TSEN54 gene to detect pathogenic variants associated with Pontocerebellar Hypoplasia Type 4 (PCH4). It aids in the diagnosis of this severe neurodev...	Peripheral Whole Blood, FTA Card, or Extracted DNA	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TSEN54 gene", "Coding exons ±10 bp intronic boundaries"] Parameters [{"name": "Sequencing Depth", "reference_range": "≥100×"}] Preparation ["No specific fasting required.", "Continue all prescribed medications unless otherwise directed by your physician."] Indications ["Clinical suspicion of Pontocerebellar Hypoplasia Type 4 (PCH4)", "Family history of PCH4", "Carrier screening for autosomal recessive disorders"] Measurement technique Confirm with laboratory Codes LOINC: 94222-4 ICD-10: Q04.8 Clinical summary This genetic test sequences the TSEN54 gene to detect pathogenic variants associated with Pontocerebellar Hypoplasia Type 4 (PCH4). It aids in the diagnosis of this severe neurodevelopmental disorder.
TEST-5507 TSEN54 Gene Pontocerebellar Hypoplasia Type 5 Genetic Test This genetic test identifies pathogenic variants in the TSEN54 gene associated with pontocerebellar hypoplasia type 5.	Peripheral whole blood or dried blood spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TSEN54 gene"] Parameters [] Preparation [] Indications ["Diagnosis of pontocerebellar hypoplasia type 5", "Family planning for PCH5"] Measurement technique Confirm with laboratory Codes LOINC: 54236-8 ICD-10: Q04.8 Clinical summary This genetic test identifies pathogenic variants in the TSEN54 gene associated with pontocerebellar hypoplasia type 5.
TEST-6163 TSFM Gene Combined Oxidative Phosphorylation Deficiency Type 3 Genetic Test This genetic test evaluates the TSFM gene for mutations associated with Combined Oxidative Phosphorylation Deficiency Type 3 (COXPD3).	Whole Blood (Peripheral)	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TSFM gene", "Coding exons and flanking intronic regions of TSFM"] Parameters [] Preparation ["No specific fasting required.", "Inform the lab of any medications being taken."] Indications ["Suspected Combined Oxidative Phosphorylation Deficiency Type 3 (COXPD3)", "Individuals with clinical features suggestive of mitochondrial disorders"] Measurement technique Confirm with laboratory Codes LOINC: 7907-2 ICD-10: E88.49 Clinical summary This genetic test evaluates the TSFM gene for mutations associated with Combined Oxidative Phosphorylation Deficiency Type 3 (COXPD3).
TEST-3622 TSPAN12 Gene Exudative Vitreoretinopathy Type 5 Genetic Test This test identifies pathogenic variants in the TSPAN12 gene associated with familial exudative vitreoretinopathy type 5.	Peripheral Whole Blood (EDTA) or FTA Card (Dried Blood Spot)	21–28 Calendar Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TSPAN12 gene sequence", "TSPAN12 gene copy number variants"] Parameters [] Preparation [] Indications ["Diagnosis of familial exudative vitreoretinopathy type 5", "Carrier screening in families with known TSPAN12 mutations"] Measurement technique Confirm with laboratory Codes LOINC: 21613-5 ICD-10: H35.0 Clinical summary This test identifies pathogenic variants in the TSPAN12 gene associated with familial exudative vitreoretinopathy type 5.
TEST-5042 TSPAN7 Gene Intellectual Developmental Disorder, X‑Linked Type 58 Genetic Test This genetic test identifies pathogenic variants, including point mutations and CNVs, within the TSPAN7 gene associated with X-linked intellectual disability type 58.	Peripheral Whole Blood or Dried Blood Spot (FTA Card)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in TSPAN7 gene", "Copy Number Variants (CNVs) in TSPAN7 gene"] Parameters [] Preparation ["No special preparation is needed.", "Pre-test genetic counselling is mandatory."] Indications ["Diagnosis of X-linked intellectual disability type 58", "Assessment of recurrence risk in families", "Confirmation of genetic aetiology for cognitive impairment"] Measurement technique Confirm with laboratory Codes LOINC: 83329-9 ICD-10: F79, Q99.8 Clinical summary This genetic test identifies pathogenic variants, including point mutations and CNVs, within the TSPAN7 gene associated with X-linked intellectual disability type 58.

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Genetics tests in Dubai & UAE

Genetics test prices

Genetics: overview

Use the test details as a conversation starter

Related Genetics categories